- Home
- XERS vs PMT Comparison
XERS vs PMT Comparison
Compare XERS & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- PMT
- Stock Information
- Founded
- XERS 2005
- PMT 2009
- Country
- XERS United States
- PMT United States
- Employees
- XERS N/A
- PMT N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- PMT Real Estate Investment Trusts
- Sector
- XERS Health Care
- PMT Real Estate
- Exchange
- XERS Nasdaq
- PMT Nasdaq
- Market Cap
- XERS 1.3B
- PMT 1.1B
- IPO Year
- XERS 2018
- PMT 2009
- Fundamental
- Price
- XERS $7.36
- PMT $12.26
- Analyst Decision
- XERS Strong Buy
- PMT Hold
- Analyst Count
- XERS 7
- PMT 6
- Target Price
- XERS $8.00
- PMT $14.20
- AVG Volume (30 Days)
- XERS 1.9M
- PMT 610.2K
- Earning Date
- XERS 11-07-2025
- PMT 10-21-2025
- Dividend Yield
- XERS N/A
- PMT 13.06%
- EPS Growth
- XERS N/A
- PMT N/A
- EPS
- XERS N/A
- PMT 0.72
- Revenue
- XERS $246,025,000.00
- PMT $614,826,000.00
- Revenue This Year
- XERS $43.89
- PMT N/A
- Revenue Next Year
- XERS $20.40
- PMT $28.12
- P/E Ratio
- XERS N/A
- PMT $17.03
- Revenue Growth
- XERS 35.62
- PMT 13.07
- 52 Week Low
- XERS $2.69
- PMT $11.70
- 52 Week High
- XERS $8.03
- PMT $14.93
- Technical
- Relative Strength Index (RSI)
- XERS 51.35
- PMT 48.32
- Support Level
- XERS $7.56
- PMT $12.36
- Resistance Level
- XERS $7.89
- PMT $12.47
- Average True Range (ATR)
- XERS 0.24
- PMT 0.20
- MACD
- XERS -0.14
- PMT 0.00
- Stochastic Oscillator
- XERS 2.90
- PMT 29.45
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.